Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease.
D000368:Aged; D000369:Aged, 80 and over; D000679:Amygdala / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D001369:Axons / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D005260:Female; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D006801:Humans; D007150:Immunohistochemistry; D016631:Lewy Bodies / Q000473:pathology / Q000648:ultrastructure; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism; D008854:Microscopy, Electron; D008875:Middle Aged; D009410:Nerve Degeneration / Q000378:metabolism / Q000473:pathology*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D016874:Neurofibrillary Tangles / Q000473:pathology / Q000648:ultrastructure; D010300:Parkinson Disease / Q000378:metabolism / Q000473:pathology*; D058225:Plaque, Amyloid / Q000473:pathology / Q000648:ultrastructure; D050683:R-SNARE Proteins; D016708:Synaptophysin / Q000378:metabolism; D051843:Synucleins; D051844:alpha-Synuclein; D051846:beta-Synuclein
D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D050683:R-SNARE Proteins; C497604:SNCA protein, human; C497607:SNCB protein, human; D016708:Synaptophysin; D051843:Synucleins; D051844:alpha-Synuclein; D051846:beta-Synuclein